원발병소 불명암의 경부림프절 전이에서 방사선치료의 역할 = Radiotherapy of Neck Node Metastases from an Unknown Primary Cancer

국문 초록 (Abstract)

목 적: 원발병소 불명암의 경부림프절 전이 환자에서 방사선치료의 결과를 분석하고자 후향적 연구를 실시하였다.
대상 및 방법: 1986년 1월부터 2005년 12월까지 원발병소 불명암의 경부림프절 전이로 진단받고 근치적 목적으로
방사선치료 또는 수술 후 방사선치료를 실시한 환자 88명을 대상으로 본 연구를 시행하였다. 환자의 중앙연령은
59세(35∼74세)이고 남자 74명, 여자 14명이었다. 조직학적으로 편평상피암이 72명, 미분화세포암이 6명, 선암이
1명이었고 조직학적으로 분류할 수 없었던 환자가 9명이었다. N 병기는 N1 병기가 4명, N2a 병기가 10명, N2b 병
기 48명, N2c 병기가 8명, N3 병기가 18명이었다. 방사선치료만 시행 받은 환자는 10명, 동시병용 방사선-항암화
학요법을 받은 환자는 27명, 수술 및 수술 후 방사선치료는 35명, 수술 및 수술 후 동시병용 방사선-항암화학요법
은 16명의 환자에서 시행되었다. 상부 경부림프절과 잠재적 원발병소인 인후두에 조사된 총 방사선량은 50.4∼
79.6 Gy (중앙값, 59.4Gy)였고, 하부 경부림프절에 조사된 총 방사선량은 50∼59.4 Gy (중앙값 50Gy)였다. 추적관
찰기간은 1∼154개월(중앙값 32개월)이었다. 결 과: 완전관해를 얻은 환자는 57명(70.4%)이었고 부분환해는 8명(9.9%)의 환자에서 관찰되었다. 전체 환자의 5년 생존율은 43.9%였으며, 5년 무병생존율은 41.7%였다. 경부절제술 여부와 원발종양 발생 여부가 생존율에 영향을 미치는 예후인자이고, N 병기와 경부절제술 여부, 원발종양 발생여부가 무병생존율에 영향을 미치는 예후인자로 분석되었다. 결 론: 원발병소 불명암의 경부 림프절 전이 환자에서 근치적 수술과 방사선치료로 좋은 생존결과를 얻을 수 있으며, 양측 경부와 잠재적 원발병소를 포함한 광범위 방사선치료는 좋은 국소 제어율과 생존율을 기대할 수 있다. 그러나 광범위 방사선치료로 인한 부작용을 줄이기 위하여 방사선치료 범위에 대한 더 많은 연구가 필요하다.

다국어 초록 (Multilingual Abstract)

Purpose: The aim of this retrospective analysis was to analyze the results of radiotherapy administered to
patients with neck node metastases from an unknown primary cancer, with or without neck dissection.
Materials and Methods: From January 1986 to December 2005, 88 patients with neck node metastases from an
unknown primary cancer were treated with curative intent. The age of the patients ranged from 35 to 74 years
(median age, 59 years). There were 74 male and 14 female patients. Distribution of patients by N status was
as follows: N1, 4 patients; N2a, 10 patients; N2b, 48 patients; N2c, 8 patients; N3, 18 patients. Fifty-one
patients underwent neck dissection and 37 patients had only a biopsy (31 patients had fine-needle aspiration
and 6 patients had an excisional biopsy). All patients received radiotherapy. The follow-up time ranged from 1
to 154 months, with a median time of 32 months. Results: The overall survival (OS) and disease-free survival (DFS) rate at 5 years were 43.9% and 41.7%, respectively. The factors associated with the OS rate were neck dissection, and a subsequent primary tumor. Factors associated with the DFS rate were N stage, neck dissection, and a subsequent primary tumor. Neck failure was noted in 15 patients, distant metastases in 18 patients, and a subsequent primary tumor in 8 patients. Conclusion: With comprehensive radiotherapy given to the bilateral neck and the potential mucosal sites, good survival rates can be obtained in patients with neck node metastases from an unknown primary cancer. However, considering the side effects, a randomized trial is required to determine the optimal radiotherapy volume.

목차 (Table of Contents)

• 서 론
• 대상 및 방법
• 결 과
• 고안 및 결론

참고문헌 (Reference)

1 Hess KR, "natural history and prognostic factors in 657 consecutive patients" 1272-1280, jclinoncol1994;12

2 Wang RC, "Unknown primary squamous cell carcinoma metastatic to the neck" 1388-1393,

3 Kim K, "Treatment outcome of metastatic carcinoma of cervical lymph node from an unknown primary" 23 : 137-142, 2005

4 Fogarty GB, "The usefulness of fluorine 18-labelled deoxyglucose positron emission tomography in the investigation of patients with cervical lymphadenopathy from an unknown primary tumor" 25 : 138-145, 2003

5 Sinnathamby K, "The occult head and neck primary: to treat or not to treat?" 9 : 322-329, 1997

6 Erkal HS, "Squamous cell carcinomas metastatic to cervical lymph nodes from an unknown head-and-neck mucosal site treated with radiation therapy alone or in combination with neck dissection" 50 : 55-63, 2001

7 Mendenhall WM, "Squamous cell carcinoma of the head and neck treated with radiation therapy the role of neck dissection for clinically positive neck nodes" 733-740,

8 Califano J, "Second esophageal tumors in patients with head and neck squamous cell carcinoma an assessment of clonal relationships" Clin Cancer Res 1999; 5 1862-1867

9 Park IK, "Radiotherapy of metastatic neck nodes from an unknown primary site" 15 : 105-111, 1997

10 Weir L, "Radiation treatment of cervical lymph node metastases from an unknown primary: an analysis of outcome by treatment volume and other prognostic factors" 35 : 206-211, 1995

11 "Postoperative radiation therapy for cervical lymph node metastases from an occult squamous cell carcinoma" 884-890, laryngoscope1992;102

12 Colletier PJ, "Postoperative radiation for squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site: outcomes and patterns of failure" 20 : 674-681, 1998

13 Friesland S, "Outcome of ipsilateral treatment for patients with metastases to neck nodes of unknown origin" 40 : 24-28, 2001

14 Kaplan EL, "Non-parametric estimations from incomplete observations" 457-481, jamstatassoc1958;53

15 Christiansen H, "Neck lymph node metastases from an unknown primary tumor retrospective study and review of literature" 181 : 355-362, 2005

16 Nguyen C, "Metastatic squamous cell carcinoma to cervical lymph nodes from unknown primary mucosal sites" she (she): 58-63,

17 Iganej S, "Metastatic squamous cell carcinoma of the neck from an unknown primary: management options and patterns of relapse" 24 : 236-246, 2002

18 Fernandez JA, "Metastatic squamous cell carcinoma in cervical lymph nodes from an unknown primary tumour: prognostic factors" 23 : 158-163, 1998

19 Aslani M, "Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection?" 29 : 585-590, 2007

20 Reddy SP, "Metastatic carcinoma in the cervical lymph nodes from an unknown primary site: results of bilateral neck plus mucosal irradiation vs. ipsilateral neck irradiation" 37 : 797-802, 1997

21 Anand AK, "Metastatic carcinoma in the cervical lymph nodes from an occult primary a conservative approach to the role of radiotherapy" 289-294,

22 Million RR, "Management of Head and Neck Cancer" Lippincott Co 311-320, 1994

23 Mendenhall WM, "Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site" 20 : 739-744, 1998

24 De Braud F, "Diagnosis and management of squamous cell carcinoma of unknown primary tumor site of the neck" seminoncol1993;20

25 Strojan P, "Combined surgery and postoperative radiotherapy for cervical lymph node metastases from an unknown primary tumour" 49 : 33-40, 1998

26 Pignon JP, "Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer" 355 : 949-955, 2000

27 Hathaway B, "Chemoradiation for metastatic SCCA: role of comorbidity" 111 : 1893-1895, 2001

28 Coster JR, "Cervical nodal metastasis of squamous cell carcinoma of unknown origin indications for withholding radiation therapy" 743-749,

29 Marcial-Vega VA, "Cervical metastases from unknown primaries radiotherapeutic management and appearance of subsequent primaries" 919-928,

30 Lapeyre M, "Cervical lymph node metastasis from an unknown primary: is a tonsillectomy necessary?" 39 : 291-296, 1997

31 Jereczek-Fossa BA, "Cervical lymph node metastases of squamous cell carcinoma from an unknown primary" 30 : 153-164, 2004

32 Grau C, "Cervical lymph node metastases from unknown primary tumours. Results from a national survey by the Danish Society for Head and Neck Oncology" 55 : 121-129, 2000

33 Nieder C, "Cervical lymph node metastases from occult squamous cell carcinoma: cut down a tree to get an apple?" 50 : 727-733, 2001

34 Nordstrom DG, "Cervical lymph node metastases from an unknown primary" 73-76,

35 Mintzer DM, "Cancer of unknown primary: changing approaches. A multidisciplinary case presentation from the Joan Karnell Cancer Center of Pennsylvania hospital" 9 : 330-338, 2004

36 Greco FA, "Cancer of unknown primary site" Philadelphia, PA: Lippincott Williams & Wilkins 2213-2236, 2005

37 Harper CS, "Cancer in neck nodes with unknown primary site: role of mucosal radiotherapy" 12 : 463-469, 1990

38 Browman GP, "Cancer Care Ontario Practice Guideline Initiative Head and Neck Cancer Disease Site Group. Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: a systematic review of the published literature with subgroup analysis" 23 : 579-589, 2001

39 Green FL, "AJCC cancer staging manual" New York, Springer 2002

40 Johnson JT, "A long-term assessment of adjuvant chemotherapy on outcome of patients with extracapsular spread of cervical metastases from squamous carcinoma of the head and neck" 77 : 181-185, 1996